KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 72 filers reported holding KRONOS BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,450 | -94.9% | 16,500 | -93.2% | 0.00% | – |
| Q2 2023 | $419,192 | -9.1% | 243,716 | -22.9% | 0.00% | – |
| Q1 2023 | $461,259 | -1.7% | 315,931 | +9.1% | 0.00% | – |
| Q4 2022 | $469,014 | -55.8% | 289,515 | -8.6% | 0.00% | – |
| Q3 2022 | $1,062,000 | +3.1% | 316,777 | +11.9% | 0.00% | – |
| Q2 2022 | $1,030,000 | -47.7% | 282,967 | +3.9% | 0.00% | -100.0% |
| Q1 2022 | $1,969,000 | -49.4% | 272,255 | -4.9% | 0.00% | 0.0% |
| Q4 2021 | $3,889,000 | -33.9% | 286,158 | +2.0% | 0.00% | -50.0% |
| Q3 2021 | $5,882,000 | +68.2% | 280,585 | +92.1% | 0.00% | +100.0% |
| Q2 2021 | $3,498,000 | +25.3% | 146,051 | +53.2% | 0.00% | 0.0% |
| Q1 2021 | $2,792,000 | +2.3% | 95,361 | +4.4% | 0.00% | 0.0% |
| Q4 2020 | $2,729,000 | – | 91,341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $9,264,000 | 8.31% |
| Omega Fund Management, LLC | 3,818,283 | $12,791,000 | 4.68% |
| Privium Fund Management (UK) Ltd | 645,331 | $2,162,000 | 2.76% |
| Wildcat Capital Management, LLC | 1,438,232 | $4,818,000 | 1.85% |
| Nextech Invest Ltd. | 1,451,537 | $4,863,000 | 1.57% |
| Alphabet Inc. | 1,438,232 | $4,818,000 | 0.25% |
| Artal Group S.A. | 1,542,954 | $5,169,000 | 0.22% |
| Perceptive Advisors | 2,156,151 | $7,223,000 | 0.21% |
| Oasis Management Co Ltd. | 196,078 | $657,000 | 0.11% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $1,767,000 | 0.10% |